Common Contracts
2 similar Clinical Trial Agreement contracts by 60 Degrees Pharmaceuticals, Inc.
CLINICAL TRIAL AGREEMENT PROTOCOL NUMBER: TQ-BA-2024-1 (NCT06207370) PROTOCOL TITLE: “Double-blind Placebo-controlled Study to Assess the Safety and Efficacy of Oral Tafenoquine plus Standard of Care versus Placebo plus Standard of Care in Patients...Clinical Trial Agreement • September 19th, 2024 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
This Clinical Trial Agreement (this “Agreement”) is effective as of the last date of signature (the “Effective Date”) and sets forth certain agreements by and between 60 DEGREES PHARMACEUTICALS, INC , having its principal place of business at 1025 Connecticut Ave NW, Washington DC, 20036 (“Sponsor”), and Rhode Island Hospital with a principal place of business at 593 Eddy Street, Providence RI 02903 (hereinafter referred to as “Institution”), The persons executing this Agreement hereby represent that they are authorized to do so for and on behalf of the above-named companies and organizations.
CLINICAL TRIAL AGREEMENT PROTOCOL NUMBER: TQ-BA-2024-1 (NCT06207370) PROTOCOL TITLE: “Double-blind Placebo-controlled Study to Assess the Safety and Efficacy of Oral Tafenoquine plus Standard of Care versus Placebo plus Standard of Care in Patients...Clinical Trial Agreement • September 19th, 2024 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations
This Clinical Trial Agreement (this “Agreement”) is effective as of July 15, 2024(the “Effective Date”) and sets forth certain agreements by and between 60 DEGREES PHARMACEUTICALS, INC , having its principal place of business at 1025 Connecticut Ave NW, Washington DC, 20036 (“Sponsor”), and YALE UNIVERSITY, a non profit corporation organized and existing under and by virtue of a special charter granted by the General Assembly of the Colony and State of Connecticut, with offices located at 25 Science Park – 3rd Floor, 150 Munson Street, New Haven, CT 06511 (hereinafter referred to as “Institution”). Subsequent reference to Institution hereinafter shall imply the inclusion of Staff (defined in Section 1.3). The persons executing this Agreement hereby represent that they are authorized to do so for and on behalf of the above-named companies and organizations.
